Results 151 to 160 of about 24,516 (282)

Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab

, 2021
Lisa C. Plymate, Gregory Pepper, Maxwell P. Krist, David M. Koelle   +3 more
openalex   +1 more source

Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome

Clinical Pharmacology: Advances and Applications, 2011
Maro Ohanian, Christian Cable, Kathleen HalkaDepartment of Hematology and Oncology, Scott and White Healthcare, The Texas A&M Health Science Center College of Medicine, Temple, TX, USAAbstract: This case report describes how eculizumab reversed ...
Ohanian M, Cable CC, Halka KK
doaj  

Optimizing the Long-Term Therapy with Eculizumab (ECU) for Atypical Hemolytic Uremic Syndrome (aHUS) [PDF]

, 2023
Luisa Santangelo, Giuseppe Stefano Netti, Sebastiano Mazza, Francesca Zito, Valeria Catalano, Marida Martino, Diletta Domenica Torres, Vincenza Carbone, Elena Ranieri, Mario Giordano   +9 more
openalex   +1 more source

Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report

Clinical Pharmacology: Advances and Applications, 2011
Maro Ohanian, Christian Cable, Kathleen Halka Department of Hematology/Oncology, Scott & White Healthcare and The Texas A&M Health Science Center, College of Medicine, Temple, TX, USA Objective: To describe how maintenance eculizumab ...
Halka K, Cable C, Ohanian M
doaj  

Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials [PDF]

, 2019
Bernd Schröppel, Enver Akalin, Mukta Baweja, Roy D. Bloom, Sander Florman, Michael J. Goldstein, Brandy Haydel, Donald E. Hricik, Sanjay Kulkarni, Matthew H. Levine, Anita Mehrotra, Anup Patel, Emilio D. Poggio, Lloyd E. Ratner, Ron Shapiro, Peter S. Heeger   +15 more
openalex   +1 more source

P815: PHARMACOKINETIC AND PHARMACODYNAMIC SIMILARITY OF ABP 959 AND ECULIZUMAB REFERENCE PRODUCT: UNBOUND ECULIZUMAB AND CH50 FROM THE RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE STUDY IN HEALTHY VOLUNTEERS

, 2022
Vladimir Hanes, Jean Pan, Daniel T. Mytych, Vincent Chow   +3 more
openalex   +1 more source

Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome [PDF]

, 2015
Harvey, Erwin, Johnson, Scott, Kincaid, John F, Vande Walle, Johan   +3 more
core   +2 more sources

Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study

, 2020
Richard J. Nowak, Srikanth Muppidi, Said R. Beydoun, Fanny O’Brien, Marcus Yountz, James F. Howard   +5 more
openalex   +1 more source

Retraction Note to: Isolated central retinal artery occlusion as an initial presentation of paroxysmal nocturnal hemoglobinuria and successful long-term prevention of systemic thrombosis with eculizumab (Jpn J Ophthalmol. 2013;57:424–8) [PDF]

, 2014
Hyun Seung Yang, So Hyun Park, Jung Ran Choi, June-Gone Kim   +3 more
openalex   +1 more source

Eculizumab como opción terapéutica en paciente con crisis renal esclerodérmica asociada a síndrome hemolítico urémico

, 2019
Alfredo Miranda Bucheli, Sergio Mora Alfonso, Lina María Saldarriaga Rivera   +2 more
openalex   +2 more sources